Hematologie
Strategia multimodală, interdisciplinară, planificată și personalizată
Hydroxyethylstarch as a replacement fluid in therapeutic plasma exchange for lupus nephritis in a Jehovah's Witness. (se deschide o fereastră nouă)
Sursă: Transfus Apher Sci 2003;28(1):101-2.
Index: PubMed 12620275
DOI: 10.1016/S1473-0502(02)00105-2
https://www.ncbi.nlm.nih.gov/pubmed/12620275 (se deschide o fereastră nouă)
Successful management of a Jehovah's Witness with thrombotic thrombocytopenic purpura unwilling to be treated with therapeutic plasma exchange. (se deschide o fereastră nouă)
Sursă: J Clin Apher 2007;22(6):330-2.
Index: PubMed 18080270
DOI: 10.1002/jca.20150
https://www.ncbi.nlm.nih.gov/pubmed/18080270 (se deschide o fereastră nouă)
Bovine hemoglobin: a nontraditional approach to the management of acute anemia in a Jehovah's Witness patient with autoimmune hemolytic anemia. (se deschide o fereastră nouă)
Sursă: J Pharm Pract 2013;26(3):257-60.
Index: PubMed 22869910
DOI: 10.1177/0897190012451928
https://www.ncbi.nlm.nih.gov/pubmed/22869910 (se deschide o fereastră nouă)
The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products. (se deschide o fereastră nouă)
Sursă: Leuk Res Rep. 2022 25;18:100355.
Index: PubMed 36338830
DOI: 10.1016/j.lrr.2022.100355
https://pubmed.ncbi.nlm.nih.gov/36338830/ (se deschide o fereastră nouă)
The use of recombinant factor VIIa in a Jehovah's Witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage. (se deschide o fereastră nouă)
Sursă: Br J Haematol 2002;119(1):286-8.
Index: PubMed 12358947
https://www.ncbi.nlm.nih.gov/pubmed/12358947 (se deschide o fereastră nouă)
Thrombotic thrombocytopenic purpura treated with vincristine in a Jehovah's Witness. (se deschide o fereastră nouă)
Sursă: Asian J Transfus Sci 2011;5(2):180-1.
Index: PubMed 21897605
DOI: 10.4103/0973-6247.83255
https://www.ncbi.nlm.nih.gov/pubmed/21897605 (se deschide o fereastră nouă)